Integrins are adhesion receptors that mediate both cellextracellular matrix and cell-cell interactions. It has also been reported that the loss of integrin a4 expression might be associated with metastasis in several cancers. However, the molecular mechanism for loss of their expression in cancers has not been explored. In the present study, we found that the integrin a4 expression is lost in human gastric cancer cell lines and that this is recovered by treatment with DNA methyltransferase inhibitor, implying transcriptional silencing by DNA methylation. Methylation-specific PCR (MSP) and bisulfite genomic DNA sequencing demonstrated the CpG methylationdependent silencing of integrin a4 expression in eight of nine (88.8%) gastric cancer cell lines and in 84.7% of 46 primary tumors. We also investigated whether the restoration of integrin a4 in integrin a4-inactivated cells affects their ability to invade extracellular matrix, using matrigel assays. Interestingly, integrin a4-stable transfectants had markedly less invasive ability than the parental cells. Taken together, these results suggest that the transcriptional repression of the integrin a4 gene is caused by aberrant DNA methylation, and that this may play an important role in human gastric carcinogenesis.
Introduction
Integrins are a superfamily of cell-surface receptors that mediate cell-cell and cell-extracellular matrix (ECM) interactions, and control metastasis by regulating the adhesive ability of tumor cells (Hynes and Lander, 1992; Miranti and Brugge, 2002) . They are heterotypic adhesion receptors composed of noncovalently associated a and b subunits (Tamkun et al., 1986) and may crosstalk with each other, thereby regulating their functionalities. Integrin a4 is composed of the cellsurface heterodimers a4b1 and a4b7, is expressed mainly on lymphoma, melanoma and fibroblasts, and is involved in cell migration and attachment (Chan et al., 1992; Hamann et al., 1994; Michetti et al., 2000) . Several studies have suggested that altered integrin a4 expression is correlated with transformation or metastasis (Rincon et al., 1992; Holzmann et al., 1998) . For example, a high expression of integrin a4 was found to be associated with the loss of tumorigenicity and a reduction in matrigel invasion by lymphoma and melanoma cells (Qian et al., 1994; Gosslar et al., 1996) . However, the mechanism of the loss of integrin a4 from cancer cells has not been explored.
Epigenetic mechanisms that involve DNA methylation and alterations of chromatin structure represent an important way of transcriptionally silencing many genes, especially tumor suppressor genes, and act as alternatives to genetic defects in human cancers. Recently, several studies have found that the methylation of the CpG island is associated with gene silencing in tumors; these include pRb, p15
Ink4b , p16 Ink4a , hMLH1 and TGF-type I receptor (Herman et al., 1996a (Herman et al., , b, 1998 Stirzaker et al., 1997; Kang et al., 1999; Song et al., 2000) . Moreover, genes silenced by DNA methylation can be reactivated by treatment with 5-aza-2 0 -deoxycytidine (5-Aza-dC), a well-established inhibitor of DNA methyltransferase (Jones and Taylor, 1980) .
In the present study, we investigated whether methylation of the integrin a4 gene inactivates integrin a4 expression in gastric cancer cells. Our findings demonstrate that integrin a4 mRNA expression is lost in the majority of gastric cancer cell lines and in primary tumors by DNA methylation, suggesting that the epigenetic inactivation of the integrin a4 gene may play a role in gastric carcinogenesis.
Results

Loss of integrin a4 expression in gastric carcinoma cells
Integrin a4 mRNA expression was analysed in nine gastric carcinoma cell lines by RT-PCR using specific primers for integrin a4 (exons 4-8). Of these gastric carcinoma cell lines, only one cell line was found to express integrin a4 mRNA (Figure 1a) . We used the demethylating agent 5-Aza-dC to investigate whether the loss of integrin a4 expression was caused by DNA methylation in integrin a4-nonexpressing cells. Treatment with 5-Aza-dC was found to restore integrin a4 expression in eight cell lines, without basal integrin a4 expression. AGS cells were exposed to increasing concentrations of 5-Aza-dC for 4 days, which resulted in the dose-dependent induction of integrin a4 mRNA (Figure 1b) , and similar results were obtained in other cell lines, that is, SNU-1, SNU-5, SNU-719 and MKN-28 (data not shown). These results suggest that the lack of integrin a4 expression is attributable to a transcription block caused by the methylation of integrin a4 DNA in human gastric carcinoma cells.
To ascertain whether the activities of both DNA methyltransferase and HDAC play a role in the loss of integrin a4 expression, a dual treatment strategy was adopted in the AGS cell line. Treatment of AGS with 5-Aza-dC alone weakly induced integrin a4 mRNA expression, but combined treatment with trichostatin A (TSA) and 5-Aza-dC synergistically increased this gene expression (Figure 1c) . However, treatment with TSA alone had no effect on integrin a4 gene expression. This synergistic effect of 5-aza and TSA was further validated by quantitative real-time PCR (Figure 1d ).
Methylation status of the integrin a4 gene in gastric cancer cell lines
Structurally, the 725-bp fragment around the translation start codon of the integrin a4 gene (GenBank Accession no. NT_005265) has a high G þ C content (70.1%) and CpG : GpC ratio of 0.84, and thus satisfies the criteria for a CpG island (Figure 2a ) (Gardiner-Garden and Frommer, 1987) . To explore the potential role of CpG island methylation on the transcriptional silencing of the integrin a4 gene, we checked the methylation status of the gene in gastric cancer cell lines by methylationspecific PCR (MSP), which allows methylated and unmethylated alleles to be specifically amplified after chemically modifying the DNA with sodium bisulfite (Herman et al., 1996a, b) . As shown in Figure 2b , SNU-484, expressing integrin a4 mRNA, showed no methylation at the integrin a4 CpG island, whereas the other Figure 1 Restoration of integrin a4 mRNA expression after 5-Aza-dC treatment. (a) Cells were treated for 4 days with DMSO (vehicle) or 5 mM of 5-Aza-dC, as described in 'Materials and methods'. RT-PCR was performed using specific primers for integrin a4. b-Actin (actin) was used as a loading control. (b) AGS was treated with 1, 5, or 10 mM of 5-Aza-dC for 4 days. (c) AGS cell line was treated with DMSO, 5 mM 5-Aza-dC (Aza), 50 nM TSA (TSA 50), 100 nM (TSA 100), or 5 mM 5-Aza-dC followed by 50 nM (Aza þ TSA 50) or 100 nM TSA (Aza þ TSA 100), as described in 'Materials and methods'. Water (DW) was used as negative control for the PCR reactions. We examined the precise methylation statuses of the integrin a4 CpG islands by bisulfite genomic sequencing ( Figure 3 ). As shown in Figure 2a , the integrin a4 CpG island was divided into two regions by the PCR primer sets used to amplify the bisulfite-modified genomic DNA. SNU-484 was, as expected, found to be hypomethylated at its integrin a4 CpG island. However, all of the 66 CpG sites examined were completely methylated in SNU-1, -601 and AGS. Consistent with the MSP results (Figure 2b ), bisulfite genomic sequencing assays also showed that the integrin a4 CpG island was half-methylated in SNU-668. Taken together, these findings strongly suggest that the methylation status of the integrin a4 CpG island is closely correlated with the expression of the integrin a4 gene in gastric cancer cell lines.
Methylation of the integrin a4 gene in primary gastric tissues
Next, we examined whether the integrin a4 gene is also methylated in primary gastric cancer tissues (Figure 4) . MSP analysis showed that 39 of 46 (84.7%) primary Figure 3 Bisulfite genomic sequencing data of the integrin a4 CpG island in gastric carcinoma cell lines. The integrin a4 CpG island was divided into two regions (BS#1 and BS#2), as defined by the specific primer sets used for the PCR amplification. The methylation statuses of the 66 CpG sites of integrin a4-positive cells (SNU-484) and of the integrin a4-negative cells (SNU-1, SNU-601, SNU-668 and AGS) were compared. Each circle indicates a CpG site and each line of circles represents the analysis of a single cloned allele. Open and closed circles represent unmethylated and methylated CpG sites (Figure 4b ). These findings demonstrate that the methylation of the integrin a4 CpG island is not an artefact of the in vitro experimental system, but rather a relatively common and cancer-related event in gastric carcinogenesis. Moreover, we correlated integrin a4 methylation status in cancer tissues with the clinicopathological data (Tables 1 and 2 ). However, aberrant methylation in primary gastric cancer tissue was not found to be significantly correlated with gender, age, histological grade, T stage or N stage.
Inhibition of invasion by expressing integrin a4
To understand the biological meaning of the methylation-based loss of integrin a4 expression in gastric carcinoma, we transfected integrin a4 cDNA into AGS cells without basal integrin a4 expression by methylation and produced a stable cell line expressing integrin a4 (denoted by AGS-a4) (Figures 5a and b) . Since the loss of integrin a4 expression has been associated with cellular invasiveness in several cancers (Qian et al., 1994; Holzmann et al., 1998; Zhu et al., 2001) , we compared the invasive ability of AGS (parental cells), AGS-c (transfected with pcDNA3.1) and AGS-a4 using a matrigel invasive assay. The results presented in Figure 5c show that AGS-a4 cells had 80% less invasive ability than the parental AGS and negative-control AGS-c cells. These findings suggest that integrin a4 expression can reduce invasion and control metastasis in gastric cancer cells.
Discussion
It is known that the loss of integrin a4 in melanoma cells and the allelic inactivation of the integrin a4 gene in fibrosarcoma cells is associated with the acquisition of a metastatic potential, which implies that the expression The results of 46 primary tissues by MSP were divided according to four possible methylation pattern Integrin a4 silencing in gastric cancer cells J Park et al of integrin a4 is involved in metastasis (Qian et al., 1994; Lobb and Hemler (1994) ; Garofalo et al., 1995; Gosslar et al., 1996; Holzmann et al., 1998; Sato et al., 1998; Felding-Habermann (2003) ; Zhu et al., 2001) . However, the molecular mechanism that inactivates or downregulates integrin a4 expression in human cancer is not known. The aberrant methylation of several genes, such as, TIMP-3, E-cadherin and beta-catenin, is known to play an important role in metastasis (Yoshiura et al., 1995; Bachman et al., 1999; Ebert et al., 2003) . More recently, several reports have linked epigenetic mechanisms with the inactivation of members of the integrin family. DNA methylation of integrin a4 was identified in a mouse liver tumor by restriction landmark genomic scanning for methylation (RLGS-M). In addition, DNA methylation and the chromatin condensation of integrin aL were detected in fibroblasts, and were suggested to contribute to the tissue-specific expression of integrin aL (Akama et al., 1997; Lu et al., 2002) . Previously, we reported that DNA methylation is one of the predominant mechanisms for inactivating various genes, like, TGF-b type I receptor, TIMP-3, p16, COX-2 and DLC-1, during gastric carcinogenesis (Kang et al., 1999; Kang et al., 2000; Song et al., 2000 Song et al., , 2001 Kim et al., 2003) . These findings led us to investigate whether integrin a4 expression could be regulated by DNA methylation, because integrin a4 expression is very low in our gastric carcinoma cells (Figure 1a) . In the present study, we observed a loss of integrin a4 mRNA expression in eight of the nine gastric cancer cell lines examined. Moreover, MSP and bisulfite genomic sequencing showed that eight of the nine gastric cell lines were hypermethylated at the CpG island of integrin a4 (Figure 2b ). In addition, treating gastric cancer cell lines, which contained methylated alleles, with 5-Aza-dC restored integrin a4 mRNA expression, demonstrating that DNA methylation is directly involved in the transcriptional silencing of the integrin a4 gene. In addition, we found that the methylation frequency of integrin a4 in cell lines (77.7%) and in primary tissues (87.4%) is very high, indicating that integrin a4 methylation is common feature in gastric cancer.
Interestingly, the methylation of integrin a4 was also observed in the corresponding gastric normal tissues (26.1%). In recent years, an accumulating number of studies have reported that DNA methylation is present in normal tissues (Issa et al., 1994; Toyooka et al., 2002; Kuroki et al., 2003; Li et al., 2003) . For example, APC methylation was observed in a majority of normal gastric mucosa (97.5%) tissue samples, and the aberrant methylation of p15, p16 and E-cadherin was commonly detected in adjacent normal gastric tissues (Tsuchiya et al., 2000; Leung et al., 2001) . A recent study, involving an investigation of the methylation of 12 genes during multistep gastric carcinogenesis, showed that hypermethylation commenced at an early stage, and that gene methylation appeared to follow a chronological order during the carcinogenesis (Kang et al., 2003) . These results imply the existence of precancerous lesions in corresponding normal tissues, and that transcription silencing by DNA methylation may be established during an early stage in multistep process of carcinogenesis.
The detachment of cells from a primary tumor is an important aspect of metastasis (Stetler-Stevenson et al., 1993) . Thus, adhesion molecules like integrins, may affect tumor progression and metastasis at many stages (Felding-Habermann, 2003) . It was reported that the restored expression of integrin a4 suppressed metastasis in lymphoma and melanoma, and it was suggested that integrin a4 may affect tumor metastasis at many stages (Qian et al., 1994; Gosslar et al., 1996; Zhu et al., 2001 ). In addition, integrin a4 was found to reduce the secretion of matrix metalloproteinase, which inhibits the invasiveness of tumor cells (Huhtala et al., 1995) . In agreement with these results, our finding that the overexpression of integrin a4 reduces the invasive ability of gastric cancer cells supports the hypothesis that the loss of integrin a4 expression may be involved in metastasis.
Recent studies have indicated the existence of a mechanistic linkage between DNA methylation and chromatin alteration, as mediated by, DNMTs, methylCpG-binding proteins and HDAC complex (Nan et al., 1998; Burgers et al., 2002) . Our results show that combined treatment with 5-Aza-dC and TSA synergistically upregulated integrin a4 mRNA expression more so than 5-Aza-dC alone in AGS cells. This result suggests that methylation plays a dominant role over histone deacetylation in DNA methylation-induced integrin a4 silencing.
In summary, our findings demonstrate that epigenetic alterations of integrin a4 CpG island occur in gastric carcinoma, and that is associated with the transcriptional silencing of the integrin a4 gene. We also show that integrin a4 upregulation may reduce the invasive ability of gastric cancer cells. Taken together, our results suggest that the loss of integrin a4 by DNA methylation may play an important role in gastric carcinogenesis.
Materials and methods
Cell line and tissue sample
Gastric cancer cell lines were obtained from the Korean Cell Line Bank (Seoul, Korea). All cell lines were maintained in RPMI1640 supplemented with 10% fetal bovine serum (Hyclone Laboratories, Inc., Logan, UT, USA) and gentamicin (10 m/ml) at 371C in a 5% CO 2 humidified atmosphere. Tumors and the corresponding normal tissues were obtained from 46 patients with primary gastric carcinoma, during surgery at the Seoul National University Hospital, Seoul, Korea. After surgical removal, the tissues were frozen immediately in liquid nitrogen and stored until required.
RT-PCR
Total RNA was isolated from 10 7 to 10 8 cultured cells using a TRI reagent kit (Molecular Research Center, Cincinnati, OH, USA). cDNA was synthesized from 1 mg of total RNA using MMLV Reverse Transcriptase (Invitrogen) with random hexamers. Integrin a4 cDNA was amplified by PCR using the sense primer 5 0 -GAA TAG CTC CGT GTT ATC AA-3 0 and antisense primer 5 0 -TAT ATG CCT TAC CAA TCT GC-3 0 . Reactions were performed in 20 mlvolumes under the following conditions: 941C for 5 min; then 35 cycles of 941C for 30 s, 531C for 30 s, and 721C for 30 s; and finally 10 min at 721C. b-Actin was used as an internal control to estimate the efficiency of the cDNA synthesis in each cell line (Jong et al., 1999) .
Quantitative real-time PCR was performed using commercially available Assay-on-demand probe-primer sets (Assay ID: Hs00168433_m1, Applied Biosystems), according to the manufacturer's guidelines (comparative C T method). We used ABI PRISM s 7900HT Sequence Detection System for PCR with 384-well plate.
Methylation-specific PCR and bisulfite genomic sequencing Bisulfite modification was performed using 'one day MSP Kit' (In2gen, Korea), according to the manufacture's instructions. The following primer sets were used; for methylated DNA, MF_a4 (5 0 -TAG AGT TAT TTC GCG TTT TGC G-3 0 ) and MR_a4 (5 0 -CTT CGA ATA CTC GCG CTA CTT-3 0 ), and for unmethylated DNA, UF_a4 (5 0 -GTT TAG AGT TAT TTT GTG TTT TGT G-3 0 ) and UR_a4 (5 0 -AAA ACT TCA AAT ACT CAC ACT ACT-3 0 ). For bisulfite genomic sequencing, of modified DNA by PCR, we used the following primer sets: BS1F (5 0 -TCT TAC TAA ACC CAA AAC CAT C-3 0 ) and BS1R (5 0 -AAG GAG AGA GGG AAG AGG A-3 0 ); BS2F (5 0 -TCC TCT TCC CTC TCT CCT T-3 0 ) and BS2R (5 0 -GTT GTG GGG GTT TTG GTA AA-3 0 ). PCR products were cloned into TA cloning vectors (Invitrogen) and sequenced.
5-Aza-DC and trichostatin (TSA) treatment
Cells were seeded at a density of 1 Â 10 6 cells/100 mm dish and treated 24 h later with varying concentrations of 5-Aza-dC (Sigma) for 4 days with media changes at 2-day intervals. For the synergistic study, cells were first incubated with 5 mM 5-Aza-dC for 48 h at 371C and then 50 or 100 nM TSA (Sigma) was added for an additional 16 h.
Plasmid and transfection pCDNA3.1(À) vector encoding human integrin a4 cDNA was a gift from Ginsburg (The Scripps Research Institute, CA, USA). AGS cells were transfected with the plasmid DNA using Lipofaminet 2000 (Invitrogen), according to the manufacturer's instructions, and then selected with 0.5 mg/ml G418 (Invitrogen) for 3-4 weeks. cDNA expression was confirmed by RT-PCR and flow cytometry.
Flow cytometry
Cell (5 Â 10 5 per sample) were washed three times with PBS containing 1% BSA, and incubated for 1 h on ice with primary integrin a4 antibody (HP2/1, Chemicon). The cells were then washed and incubated with FITC-conjugated rabbit antimouse IgG (The Jackson Laboratory) for 1 h on ice. Fluorescence was measured using a FACSCalibur flow cytometer.
Invasion assay
The invasion assay was carried out in the 24-well BD BioCoatt Matrigelt Invasion Camber (Becton Dickinson). After the matrigel inserts had been preincubated with serum-free medium for 2 h at 371C, the lower chamber was filled with complete medium. Cells (2.5 Â 10 4 cells/well) were then seeded into the upper compartment in serum-free medium, incubated for 48 h in a tissue culture incubator, washed with PBS and fixed with 4% paraformaldehyde. The filter was stained with 0.1% crystal violet and the cells in the upper chamber were wiped off. Migrated cells were counted in four separated fields per well. Each data point shown represents the mean of three wells.
